RenovoRx RNXT
NASDAQ RNXT
$1.32 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Income towards Parent Company (2020 - 2026)

RenovoRx (RNXT) posted Income towards Parent Company of -$3.5 million for Q1 2026, up 1.14% sequentially from -$3.5 million in Q4 2025, and down 1.66% YoY from -$3.5 million in Q1 2025.

RenovoRx (RNXT) Income towards Parent Company (2020 - 2026) Analysis & Trends

RenovoRx has reported Income towards Parent Company for 7 years, with the latest figure at -$3.5 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 1.66% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.7 million (up 49.53% YoY) and the FY2025 annual result came in at -$32.3 million, down 16.42% from the prior year.
  • Income towards Parent Company improved to -$3.5 million in Q1 2026 per RNXT's latest filing, from -$3.5 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$2.7 million in Q4 2023 and troughed at -$19.4 million in Q4 2024.
  • A 5-year average of -$4.5 million and a median of -$3.4 million in 2025 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company plunged 612.51% in 2024, then jumped 81.86% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$3.1 million in 2022, then rose by 12.04% to -$2.7 million in 2023, then slumped by 612.51% to -$19.4 million in 2024, then surged by 81.86% to -$3.5 million in 2025, then grew by 1.14% to -$3.5 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$3.5 million, -$3.5 million, and -$4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 RenovoRx 62.20 Mn 62.20 Mn 766,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.77 Mn
Mar 31, 2026 -3.48 Mn
Dec 31, 2025 -3.52 Mn
Sep 30, 2025 -4.06 Mn
Jun 30, 2025 -3.67 Mn
Mar 31, 2025 -3.43 Mn
Dec 31, 2024 -19.42 Mn
Sep 30, 2024 -3.02 Mn
Jun 30, 2024 -3.32 Mn
Mar 31, 2024 -3.02 Mn
Dec 31, 2023 -2.73 Mn
Sep 30, 2023 -3.33 Mn
Jun 30, 2023 -4.23 Mn
Mar 31, 2023 -5.39 Mn
Dec 31, 2022 -3.10 Mn
Sep 30, 2022 -2.88 Mn
Jun 30, 2022 -3.33 Mn
Mar 31, 2022 -4.31 Mn
Dec 31, 2021 -1.62 Mn
Sep 30, 2021 -5.21 Mn